Progressive Supranuclear Palsy (PSP)

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain

Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes

Synaptic Loss in Multiple System Atrophy

The CurePSP Genetics Program

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

ADDIA Proof-of-Performance Clinical Study

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

Human CNS Tau Kinetics in Tauopathies

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK

Safety Study of TPI-287 to Treat CBS and PSP

Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)

Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies